Human Regular Insulin (Humulin)

07/01/1998 - "In a 35-year-old woman with long-term IDDM and delayed absorption of subcutaneously applied human regular insulin, a 3-year CIPII with human regular insulin via a percutaneous access device was complicated by three catheter obstructions and one subcutaneous abscess. "
08/01/2001 - "Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus."
11/28/1997 - "Twenty patients from Auckland, with insulin dependent diabetes mellitus, received lispro for 3 months and Humulin R for 3 months in a crossover design. "
08/01/1997 - "A 5-month open study was performed in 66 IDDM patients after they had been transferred from human regular insulin to insulin lispro as a premeal therapy. "
11/28/1997 - "Lispro insulin as premeal therapy in type 1 diabetes: comparison with Humulin R."

06/01/2007 - "The aim of this prospective observational open-label controlled study was to compare the effects of aspart and human regular insulin resulting from their sequential long-lasting routine administration in small preprandial boluses to individuals with type 2 diabetes according to identical algorithms. "
08/01/2021 - "Treatment Patterns and Outcomes, Before and After Humulin R U-500 Initiation, Among High-Dose Type 2 Diabetes Mellitus Patients in the United States."
05/01/2004 - "In combination with the HOMA, it is intra-abdominal fat, and not subcutaneous abdominal fat, which explains 50 - 75 % of the variability of the effect of sc human regular insulin in patients with type 2 diabetes."
05/01/2004 - "Dependency of the metabolic effect of sc-injected human regular insulin on intra-abdominal fat in patients with type 2 diabetes."
01/01/2010 - "This study compared the effect of VIAject with human regular insulin and insulin lispro on postprandial oxidative stress and endothelial function in patients with type 2 diabetes. "

06/01/2000 - "Subjects received 0.08 U/kg body wt human regular insulin as an intravenous bolus to produce moderate self-limited hypoglycemia. "
02/01/2018 - "The mean blood glucose levels of humulin group, low-intensity group, high-intensity group were decreased (mmol/L: 10.2±3.2, 8.4±2.6, 8.1±2.2), the blood glucose target-reaching rate were increased [40.2% (3 295/8 196), 71.1% (5 393/7 585), 80.4% (6 286/7 818)], the blood glucose target-reaching time were shortened (hours: 49.1±5.8, 24.6±4.6, 17.5±4.2), the hypoglycemia rates were increased respectively [1.3% (108/8 196), 2.8% (211/7 585), 4.0% (313/7 818)], with statistically significant differences (all P = 0.000). "
03/01/2008 - "Different brain responses to hypoglycemia induced by equipotent doses of the long-acting insulin analog detemir and human regular insulin in humans."
11/01/2002 - "The patients underwent an insulin-induced hypoglycemia test by intravenously administering human regular insulin. "
08/01/2001 - "Human regular insulin peaks at 2 to 3 hours after injection; thus, checking blood glucose at the 2-hour point is a relic of strategies to prevent hypoglycemia. "

03/01/2007 - "After first subcutaneous dose of human regular insulin, severe local allergic reaction developed. "
07/01/2020 - "Rapid insulin desensitization is possible to allow treatment of DKA with human regular insulin IV in patients with known insulin allergy."
09/01/2003 - "We also experienced a patient with insulin allergy not only to human regular insulin but also to both of the insulin analogues. "
01/01/2005 - "[Insulin Lispro as an alternative for insulin Humulin U in the treatment of an obese gestational diabetic woman with allergy to Humulin U. "
02/01/2013 - "The patient developed allergy to human regular insulin and insulin analogs (insulin aspart and insulin glargine), which was resolved by subcutaneous insulin desensitization."

08/01/1992 - "Twice-daily humulin ultralente insulin decreases morning fasting hyperglycemia."
02/01/2018 - "Simulated artificial pancreas consisted of Guardian real time glucose monitoring system (GRT system), close-circle control algorithm and micro-pump; subcutaneous injection of Humulin 70/30 was applied to modulate stress hyperglycemia in humulin group. "
07/01/2005 - "We examined the extent to which priming the liver with a pulse of Humulin or the insulin analog hexyl-insulin monoconjugate 2 (HIM2) reduces postprandial hyperglycemia. "
11/01/2004 - "Using human regular insulin to control mealtime hyperglycemia is similarly problematic, and thus recently developed rapid-acting insulin analogues, such as lispro and aspart, are now preferred for prandial glucose control. "
06/09/1997 - "Compared with human regular insulin therapy, mealtime therapy with insulin lispro reduced postprandial hyperglycemia and may decrease the rate of mild hypoglycemic episodes in patients with NIDDM."